Health Care & Life Sciences » Biotechnology | Dynavax Technologies Corp.

Dynavax Technologies Corp. | Mutual Funds

Mutual Funds that own Dynavax Technologies Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
SPDR S&P Biotech ETF
4,598,862
7.35%
11,832
1.09%
09/06/2018
Eagle Small Cap Growth Fund
1,636,176
2.61%
1,636,176
0.39%
06/29/2018
Vanguard Total Stock Market Index Fund
1,595,121
2.54%
0
0%
07/31/2018
iShares Russell 2000 ETF
1,304,971
2.08%
-696
0.04%
09/06/2018
Fidelity Select Biotechnology Portfolio
1,274,698
2.04%
0
0.19%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
1,118,060
1.79%
38,500
0.67%
06/30/2018
Federated Kaufmann Fund
1,106,127
1.77%
-793,873
0.23%
06/29/2018
Franklin Small Cap Growth Fund
837,600
1.34%
837,600
0.39%
03/31/2018
Vanguard Extended Market Index Fund
729,598
1.17%
15,900
0.01%
07/31/2018
Franklin Biotechnology Discovery Fund
661,670
1.06%
293,600
0.63%
03/31/2018

About Dynavax Technologies

View Profile
Address
2929 Seventh Street
Berkeley California 94710
United States
Employees -
Website http://www.dynavax.com
Updated 07/08/2019
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.